Skip to main content

Table 2 Baseline laboratory evaluation

From: The role of enteric hormone GLP-2 in the response of bone markers to a mixed meal in postmenopausal women with type 2 diabetes mellitus

Variable

Reference range

Groups T2D (n = 23)

Group CO (n = 20)

p-value

Mean (SD)

Mean (SD)

FSH (IU/L)

31 to 134

49.7 (16.5)

78.1 (13.4)

< 0.001

LH (IU/L)

15 to 64

24.2 (12.4)

36.2 (11.4)

0.012

Estradiol (pg/mL)

<25

15.7 (2.7)

17,9 (6.0)

0.15

Total calcium (mg/dL)

8.6 to 10.2

9.6 (0.6)

9.3 (0.6)

0.129

Phosphorus (mg/dL)

2.7 to 4.5

3.9 (0.5)

3.6 (0.5)

0.164

PTH (pg/mL)

16 to 87

45.3 (18.8)

51.1 (17.0)

0.237

25-OHD (ng/mL)

30 to 100

21.3 (8.5)

20.4 (5.2)

0.685

CTX (ng/mL)

0.142 to 1.351

0.49 (0.25)

0.66 (0.22)

0.04

Osteocalcin (ng/mL)

5 to 25

10.2 (5.4)

14.8 (5.3)

0.008

GLP-2 (ng/mL)

1 to 6415

4.1 (2.0)

3.8 (1.8)

0.61

24-hour urinary calcium (mg/24 h)

100 to 320

174.7 (91.6)

151.9 (63.2)

0.44

  1. T2D, type 2 diabetes; CO, control; SD, standard deviation; p-value, Student’s t-test p-value; FSH, follicle-stimulating hormone; LH, luteinizing hormone; PTH, parathyroid hormone; CTX, C-terminal telopeptide of type I collagen; GLP-2, Glucagon-like peptide 2.